Figure 2.

Serum IL-17 and TGF-β1 levels in patients of three groups (pg/mL). # indicated P < 0.05 comparing with control group; △ represented P < 0.05 comparing with SKYD group.

Serum IL-17 and TGF-β1 levels in patients of three groups (pg/mL). # indicated P < 0.05 comparing with control group; △ represented P < 0.05 comparing with SKYD group.